Low risk of anti-human leukocyte antigen antibody sensitization after combined kidney and islet transplantation

Transplantation

Volumn 86, Issue 2, 2008, Pages 357-359

  Ferrari Lacraz, Sylvie ^a   Berney, Thierry ^a   Morel, Philippe ^a   Marangon, Nicola ^a   Hadaya, Karine ^a   Demuylder Mischler, Sandrine ^a   Pongratz, Gilles ^a   Pernin, Nadine ^a   Villard, Jean ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Anti HLA antibody; Islet transplantation; Kidney transplantation; Sensitization

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; HLA ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS; HLA ANTIGEN; IMMUNOSUPPRESSIVE AGENT;

ADULT; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; FEMALE; GRAFT REJECTION; HUMAN; IMMUNIZATION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MALE; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; RECIPIENT; RISK FACTOR; SENSITIZATION; SOLID; CHEMISTRY; HISTOCOMPATIBILITY TEST; IMMUNOLOGY; INSTRUMENTATION; METHODOLOGY; MIDDLE AGED; PANCREAS ISLET; PATHOLOGY; TIME;

ADULT; COHORT STUDIES; FEMALE; GRAFT REJECTION; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RISK FACTORS; TIME FACTORS;

EID: 49249099606     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31817ba628     Document Type: Article

References (21)

1. BerneyT, Bucher P,MatheZ, et al. Islet of Langerhans allogeneic trans-plantationatthe UniversityofGenevainthe steroid free erainislet after kidney and simultaneous islet-kidney transplantations. Transplant Proc 2004; 36: 1121.
2. Toso C, Baertschiger R, Morel P, et al. Sequential kidney/islet transplantation: Efficacy and safety assessment of a steroid-free immuno-suppression protocol. Am J Transplant2006; 6: 1049.
3. Badet L, Benhamou PY, Wojtusciszyn A, et al. Expectations and strat- egies regarding islet transplantation: Metabolic data from the GRAGIL 2 trial. Transplantation2007; 84: 89.
4. Mao Q, Terasaki PI, Cai J, et al. Analysis of HLA class I specific antibodies in patients with failed allografts. Transplantation2007; 83: 54.
5. Campbell PM, Senior PA, Salam A, et al. High risk of sensitization after failed islet transplantation. Am J Transplant2007; 7: 2311.
6. Cardani R, Pileggi A, Ricordi C, et al. Allosensitization of islet allograft recipients. Transplantation2007; 84: 1413.
7. Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free im-munosuppressive regimen. N Engl J Med 2000; 343: 230.
8. Akalin E, Pascual M. Sensitization after kidney transplantation. Clin J Am Soc Nephrol 2006; 1: 433.
9. Hourmant M, Cesbron-Gautier A, Terasaki PI, et al. Frequency and clinical implicationsof developmentofdonor-specific and non-donor-specific HLA antibodies after kidney transplantation. J Am Soc Nephrol 2005; 16: 2804.
10. Rickels MR, Kamoun M, Kearns J, et al. Evidence for allograft rejection in an islet transplant recipient and effect on beta-cell secretory capacity. J Clin Endocrinol Metab 2007; 92: 2410.
11. Mao Q, Terasaki PI, Cai J, et al. Extremely high association between appearance of HLA antibodies and failureof kidney grafts ina five-year longitudinal study. Am J Transplant2007; 7: 864.
12. Terasaki PI, Cai J. Humoral theory of transplantation: Further evidence. Curr Opin Immunol 2005; 17: 541.
13. SusalC, Opelz G. Kidney graft failure and presensitization against HLA class I and class II antigens. Transplantation2002; 73: 1269.
14. Campbell PM, Salam A, Ryan EA, et al. Pretransplant HLA antibodies are associated with reduced graft survival after clinical islet transplantation. Am J Transplant2007; 7: 1242.
15. House AA, Chang PC, Luke PP, et al. Re-exposureto mismatched HLA class I is a significant risk factor for graft loss: Multivariable analysis of 259 kidney retransplants. Transplantation2007; 84: 722.
16. Lerut J, Sanchez-Fueyo A. An appraisal of tolerance in liver transplantation. Am J Transplant2006; 6: 1774.
17. van Kampen CA, van de LP, Duinkerken G, et al. Alloreactivity against repeated HLA mismatches of sequential islet grafts transplanted in non-uremic type 1 diabetes patients. Transplantation2005; 80: 118.
18. Ryan EA, Paty BW, Senior PA, et al. Five-year follow-up after clinical islet transplantation. Diabetes 2005; 54: 2060.
19. Gebel HM, Bray RA. Sensitization and sensitivity: Defining the unsensitized patient. Transplantation2000; 69: 1370.
20. Martin L, Guignier F, Mousson C, et al. Detection of donor-specific anti-HLA antibodies with flow cytometryin eluates and sera from renal transplant recipients with chronic allograft nephropathy. Transplantation2003; 76: 395.
21. Oberholzer J, Triponez F, Mage R, et al. Human islet transplantation: Lessons from 13 autologous and 13 allogeneic transplantations. Transplantation2000; 69: 1115.